0.0002
0.0000
(0.00%)
At close: January 13 at 1:43:59 PM EST
Breakdown
TTM
12/31/2022
12/31/2021
12/31/2020
Total Revenue
414,876.0000
470,743.0000
637,611.0000
656,780.0000
Cost of Revenue
127,525.0000
142,890.0000
177,597.0000
206,852.0000
Gross Profit
287,351.0000
327,853.0000
460,014.0000
449,928.0000
Operating Expense
504,753.0000
569,009.0000
714,019.0000
634,901.0000
Operating Income
-217,402.0000
-241,156.0000
-254,005.0000
-184,973.0000
Net Non Operating Interest Income Expense
-28,187.0000
-17,961.0000
-23,154.0000
-45,010.0000
Other Income Expense
-11,719.0000
-19,378.0000
-57,223.0000
-45,394.0000
Pretax Income
-257,308.0000
-278,495.0000
-334,382.0000
-275,377.0000
Tax Provision
1,378.0000
-642.0000
1,268.0000
3,122.0000
Net Income Common Stockholders
-82,711.0000
-86,404.0000
-102,442.0000
-78,366.0000
Average Dilution Earnings
-175,975.0000
-191,449.0000
-233,208.0000
-200,133.0000
Diluted NI Available to Com Stockholders
-258,686.0000
-277,853.0000
-335,650.0000
-278,499.0000
Basic EPS
-0.65
-0.71
-0.87
-0.71
Diluted EPS
-0.65
-0.71
-0.87
-0.72
Basic Average Shares
126,610.5600
121,312.5800
118,360.8010
109,854.3600
Diluted Average Shares
395,381.3200
390,210.9850
387,775.8900
385,200.4420
Total Operating Income as Reported
-239,648.0000
-262,113.0000
-259,284.0000
-217,464.0000
Total Expenses
632,278.0000
711,899.0000
891,616.0000
841,753.0000
Net Income from Continuing & Discontinued Operation
-82,711.0000
-86,404.0000
-102,442.0000
-78,366.0000
Normalized Income
-65,136.6600
-65,488.9140
-63,817.7000
-44,587.4400
Interest Expense
28,187.0000
17,961.0000
23,154.0000
45,010.0000
Net Interest Income
-28,187.0000
-17,961.0000
-23,154.0000
-45,010.0000
EBIT
-229,121.0000
-260,534.0000
-311,228.0000
-230,367.0000
EBITDA
-161,831.0000
-186,139.0000
-241,115.0000
-173,977.0000
Reconciled Cost of Revenue
127,525.0000
142,890.0000
177,597.0000
206,852.0000
Reconciled Depreciation
67,290.0000
74,395.0000
70,113.0000
56,390.0000
Net Income from Continuing Operation Net Minority Interest
-82,711.0000
-86,404.0000
-102,442.0000
-78,366.0000
Total Unusual Items Excluding Goodwill
-22,246.0000
-20,957.0000
-52,910.0000
-46,272.0000
Total Unusual Items
-22,246.0000
-20,957.0000
-52,910.0000
-46,272.0000
Normalized EBITDA
-139,585.0000
-165,182.0000
-188,205.0000
-127,705.0000
Tax Rate for Calcs
0.0002
0.0000
0.0003
0.0003
Tax Effect of Unusual Items
-4,671.6600
-41.9140
-14,285.7000
-12,493.4400
12/31/2020 - 9/12/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
87N.F Stevanato Group S.p.A.
21.20
-0.93%
INND InnerScope Hearing Technologies, Inc.
0.0265
-10.17%
PDEX Pro-Dex, Inc.
46.74
-0.49%
AVTR Avantor, Inc.
22.02
+1.66%
WRBY Warby Parker Inc.
25.09
-0.91%
BNGO Bionano Genomics, Inc.
0.2229
-1.63%
POAI Predictive Oncology Inc.
1.2800
-5.88%
ALGN Align Technology, Inc.
213.68
+0.74%
MBOT Microbot Medical Inc.
1.7800
-7.77%
GCTK GlucoTrack, Inc.
0.1497
+27.95%